Pseudorabies virus protein
US5352575A · kind A · utility
6Cited by
7References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 1990 |
| Grant date | Oct 4, 1994 |
| Priority date | — |
| Expiry date | Apr 20, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides recombinant DNA molecules comprising a sequence encoding a pseudorabies virus (PRV) glycoprotein selected from the group consisting of gI, gp50, and gp63, host cells transformed by said recombinant DNA molecule sequences, the gI, gp50 and gp63 polypeptides. The present invention also provides subunit vaccines for PRV, methods for protecting animals against PRV infection and methods for distinguishing between infected and vaccinated animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.